<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(4)</volume><submitter>Pham CV</submitter><funding>Ministry of Education, Science and Technology</funding><funding>National Research Foundation of Korea</funding><pubmed_abstract>Until now, there are no publications about the preformulation studies on (S)-zaltoprofen ((S)-ZPF). Hence, we first investigated the solubility of (S)-ZPF, screened solubilizers and performed the pharmacokinetic study of (S)-ZPF in the presence of the solubilizers. The measurement of the solubility of (S)-ZPF in 26 different solvents was carried out, including d-alpha tocopheryl polyethylene glycol 1000 succinate (TPGS), 2-hydroxypropyl-β-cyclodextrin (HPCD), and mixtures of individual solvent. The plasma concentration of (S)-ZPF and the amount of (S)-ZPF retained in stomach were determined after oral (35.0 mg/kg) and intravenous (5.0 mg/kg) administration. The solubility of (S)-ZPF showed an increase of 484-fold in TPGS compared to its aqueous solubility. There was a significant increase </pubmed_abstract><journal>Asian journal of pharmaceutical sciences</journal><pagination>435-444</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7032178</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A thorough analysis of the effect of surfactant/s on the solubility and pharmacokinetics of (S)-zaltoprofen.</pubmed_title><pmcid>PMC7032178</pmcid><pubmed_authors>Jung SH</pubmed_authors><pubmed_authors>Park JH</pubmed_authors><pubmed_authors>Baek JS</pubmed_authors><pubmed_authors>Cho CW</pubmed_authors><pubmed_authors>Pham CV</pubmed_authors><pubmed_authors>Kang JS</pubmed_authors></additional><is_claimable>false</is_claimable><name>A thorough analysis of the effect of surfactant/s on the solubility and pharmacokinetics of (S)-zaltoprofen.</name><description>Until now, there are no publications about the preformulation studies on (S)-zaltoprofen ((S)-ZPF). Hence, we first investigated the solubility of (S)-ZPF, screened solubilizers and performed the pharmacokinetic study of (S)-ZPF in the presence of the solubilizers. The measurement of the solubility of (S)-ZPF in 26 different solvents was carried out, including d-alpha tocopheryl polyethylene glycol 1000 succinate (TPGS), 2-hydroxypropyl-β-cyclodextrin (HPCD), and mixtures of individual solvent. The plasma concentration of (S)-ZPF and the amount of (S)-ZPF retained in stomach were determined after oral (35.0 mg/kg) and intravenous (5.0 mg/kg) administration. The solubility of (S)-ZPF showed an increase of 484-fold in TPGS compared to its aqueous solubility. There was a significant increase </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2025-05-31T22:38:06.983Z</modification><creation>2025-05-31T22:38:06.983Z</creation></dates><accession>S-EPMC7032178</accession><cross_references><pubmed>32104472</pubmed><doi>10.1016/j.ajps.2018.10.002</doi></cross_references></HashMap>